Melanocytes Derived from Transgene-free Human Induced Pluripotent Stem Cells

Overview

Journal J Invest Dermatol

Publisher Elsevier

Specialty Dermatology

Date 2013 Mar 22

PMID 23514962

Citations 15

Authors

Jennifer C Jones

Karen Sabatini

Xiaoyan Liao

Ha T Tran

Candace L Lynch

Robert E Morey

Victoria Glenn-Pratola

Francesca S Boscolo

Qinghong Yang

Mana M Parast

Ying Liu

Suzanne E Peterson

Louise C Laurent

Jeanne F Loring

Yu-Chieh Wang

Affiliations

Soon will be listed here.

Citing Articles

Melanocytes in regenerative medicine applications and disease modeling.

Coutant K, Magne B, Ferland K, Fuentes-Rodriguez A, Chancy O, Mitchell A J Transl Med. 2024; 22(1):336.

PMID: 38589876 PMC: 11003097. DOI: 10.1186/s12967-024-05113-x.

Generating Functional and Highly Proliferative Melanocytes Derived from Human Pluripotent Stem Cells: A Promising Tool for Biotherapeutic Approaches to Treat Skin Pigmentation Disorders.

Saidani M, Darle A, Jarrige M, Polveche H, El Kassar L, Julie S Int J Mol Sci. 2023; 24(7).

PMID: 37047372 PMC: 10094141. DOI: 10.3390/ijms24076398.

Advanced Therapy Medicinal Products in Vitiligo; Current Status, Future Prospect, and Approved Treatments.

Ghashghaei S, Abbaszadeh M, Karimi S, Ataie-Fashtami L, Bajouri A, Vosough M Cell J. 2023; 25(3):143-157.

PMID: 37038694 PMC: 10105300. DOI: 10.22074/cellj.2023.557550.1067.

Induced pluripotent stem cells reprogramming overcomes technical limitations for highly pigmented adult melanocyte amplification and integration in 3D skin model.

Cohen C, Flouret V, Herlyn M, Fukunaga-Kalabis M, Li L, Bernerd F Pigment Cell Melanoma Res. 2022; 36(2):232-245.

PMID: 36478412 PMC: 10731472. DOI: 10.1111/pcmr.13077.

Highly Effective Protocol for Differentiation of Induced Pluripotent Stem Cells (iPS) into Melanin-Producing Cells.

Sulkowski M, Kot M, Badyra B, Paluszkiewicz A, Plonka P, Sarna M Int J Mol Sci. 2021; 22(23).

PMID: 34884599 PMC: 8657900. DOI: 10.3390/ijms222312787.

References

Fang D, Leishear K, Nguyen T, Finko R, Cai K, Fukunaga M . Defining the conditions for the generation of melanocytes from human embryonic stem cells. Stem Cells. 2006; 24(7):1668-77. DOI: 10.1634/stemcells.2005-0414. View

Yamane T, Hayashi S, Mizoguchi M, Yamazaki H, Kunisada T . Derivation of melanocytes from embryonic stem cells in culture. Dev Dyn. 2000; 216(4-5):450-8. DOI: 10.1002/(SICI)1097-0177(199912)216:4/5<450::AID-DVDY13>3.0.CO;2-0. View

Ohta S, Imaizumi Y, Okada Y, Akamatsu W, Kuwahara R, Ohyama M . Generation of human melanocytes from induced pluripotent stem cells. PLoS One. 2011; 6(1):e16182. PMC: 3020956. DOI: 10.1371/journal.pone.0016182. View

Lin J, Fisher D . Melanocyte biology and skin pigmentation. Nature. 2007; 445(7130):843-50. DOI: 10.1038/nature05660. View

Nissan X, Larribere L, Saidani M, Hurbain I, Delevoye C, Feteira J . Functional melanocytes derived from human pluripotent stem cells engraft into pluristratified epidermis. Proc Natl Acad Sci U S A. 2011; 108(36):14861-6. PMC: 3169131. DOI: 10.1073/pnas.1019070108. View

Thody A . alpha-MSH and the regulation of melanocyte function. Ann N Y Acad Sci. 2000; 885:217-29. DOI: 10.1111/j.1749-6632.1999.tb08679.x. View

Pla P, Alberti C, Soloveva O, Pasdar M, Kunisada T, Larue L . Ednrb2 orients cell migration towards the dorsolateral neural crest pathway and promotes melanocyte differentiation. Pigment Cell Res. 2005; 18(3):181-7. DOI: 10.1111/j.1600-0749.2005.00230.x. View

Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K . Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007; 131(5):861-72. DOI: 10.1016/j.cell.2007.11.019. View

Muller F, Schuldt B, Williams R, Mason D, Altun G, Papapetrou E . A bioinformatic assay for pluripotency in human cells. Nat Methods. 2011; 8(4):315-7. PMC: 3265323. DOI: 10.1038/nmeth.1580. View

10.

Fistarol S, Itin P . Disorders of pigmentation. J Dtsch Dermatol Ges. 2009; 8(3):187-201. DOI: 10.1111/j.1610-0387.2009.07137.x. View

11.

Rees J . The genetics of human pigmentary disorders. J Invest Dermatol. 2011; 131(E1):E12-3. DOI: 10.1038/skinbio.2011.5. View

12.

Yang R, Jiang M, Kumar S, Xu T, Wang F, Xiang L . Generation of melanocytes from induced pluripotent stem cells. J Invest Dermatol. 2011; 131(12):2458-66. PMC: 3213325. DOI: 10.1038/jid.2011.242. View

13.

Fusaki N, Ban H, Nishiyama A, Saeki K, Hasegawa M . Efficient induction of transgene-free human pluripotent stem cells using a vector based on Sendai virus, an RNA virus that does not integrate into the host genome. Proc Jpn Acad Ser B Phys Biol Sci. 2009; 85(8):348-62. PMC: 3621571. DOI: 10.2183/pjab.85.348. View

14.

MacArthur C, Fontes A, Ravinder N, Kuninger D, Kaur J, Bailey M . Generation of human-induced pluripotent stem cells by a nonintegrating RNA Sendai virus vector in feeder-free or xeno-free conditions. Stem Cells Int. 2012; 2012:564612. PMC: 3328201. DOI: 10.1155/2012/564612. View

15.

Wang Y, Nakagawa M, Garitaonandia I, Slavin I, Altun G, Lacharite R . Specific lectin biomarkers for isolation of human pluripotent stem cells identified through array-based glycomic analysis. Cell Res. 2011; 21(11):1551-63. PMC: 3364725. DOI: 10.1038/cr.2011.148. View